Satellite-based GNSS Augmentation System Market Players:
- SES S.A
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Airbus SE
- Thales Group
- Raytheon Company
- Loral Space & Communications
- Mitsubishi Motors Corporation
- SkyTraq Technology, Inc.
- Honeywell International Inc.
- Universal Avionics Systems Corporation
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of satellite-based GNSS augmentation system is estimated at USD 12.7 billion.
The global satellite-based GNSS augmentation system market size was over USD 11.98 billion in 2025 and is anticipated to witness a CAGR of around 6.7%, crossing USD 22.91 billion revenue by 2035.
Europe in the satellite-based GNSS augmentation system market is anticipated to command around 35% revenue share by 2035, impelled by rising adoption of advanced technologies, expanding Galileo and EGNOS utilization, and increasing internet and smart device penetration.
Key players in the market include Escape Therapeutics, Inc., Regen BioPharma, Inc., ThermoGenesis Holdings, Inc., CSG-BIO Company, Inc. (CellSave), CBR Systems, Inc., Pluristem Inc., Global Cord Blood Corporation, ViaCord, LLC, Cynata Therapeutics Limited.
